Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La RochefiledCriticalHoffmann La Roche
Publication of UY27547A1publicationCriticalpatent/UY27547A1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Chemical Or Physical Treatment Of Fibers
(AREA)
Enzymes And Modification Thereof
(AREA)
Abstract
La presente invención se refiere a un método para la identificación de enzimas que se expresan preferencialmente en ciertos tejidos tumorales en comparación con tejidos o células normales de crecimiento rápido, la utilización de tales enzimas para el diseno del compuesto para generar una sustancia anticancerígena basados en dichas enzimas, sus sales farmacéuticamente aceptables así como la composición farmacéutica de las mismas.The present invention relates to a method for the identification of enzymes that are preferentially expressed in certain tumor tissues compared to normal rapidly growing tissues or cells, the use of such enzymes for the design of the compound to generate an anticancer substance based on said enzymes, their pharmaceutically acceptable salts as well as the pharmaceutical composition thereof.
UY27547A2001-11-232002-11-22
METHOD FOR THE IDENTIFICATION OF TUMOR MARKING ENZYMES
UY27547A1
(en)
Substituted n-hydroxy-3-phenylprop-2-enmide and n-hydroxy-3-phenylpropanamide derivative compounds; deacetylase enzyme inhibitors; its pharmaceutical composition; Useful in the treatment of cancer, tumors, psoriasis, Alzheimer's, among others.